| Kristie A Toman, DO | |
|
765 W Interstate Ave, Bismarck, ND 58503-0936 | |
| (701) 323-3700 | |
| (701) 323-3710 |
| Full Name | Kristie A Toman |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 765 W Interstate Ave, Bismarck, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548452733 | NPI | - | NPPES |
| 15362 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 11660 (North Dakota) | Secondary |
| 208000000X | Pediatrics | 49245 (Minnesota) | Primary |
| Entity Name | Sanford Bismarck |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811941172 PECOS PAC ID: 9739098575 Enrollment ID: O20031105000403 |
News Archive
A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.
A well-known genetic risk factor for Alzheimer's disease triggers a cascade of signaling that ultimately results in leaky blood vessels in the brain, allowing toxic substances to pour into brain tissue in large amounts, scientists report May 16 in the journal Nature.
Zimbabwean antiretroviral drug manufacturers are seeking certification from the World Health Organization to receive U.N. and other multilateral agency funding to produce more affordable antiretroviral drugs.
Researchers at Huntsman Cancer Institute at the University of Utah (U of U) presented the first outcomes evaluation of an adult oncology hospital-at-home program today at the 2020 American Society of Clinical Oncology annual meeting.
Health care has much to learn from innovative high-tech companies, but not in the way most people think, according to a Perspective published today in the New England Journal of Medicine and authored by innovation experts from the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. Innovation, they say, can most effectively achieve meaningful outcomes by testing many new ideas quickly, cheaply, and contextually.
› Verified 4 days ago
| Entity Name | Mid Dakota Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275587826 PECOS PAC ID: 9638072895 Enrollment ID: O20040127001063 |
News Archive
A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.
A well-known genetic risk factor for Alzheimer's disease triggers a cascade of signaling that ultimately results in leaky blood vessels in the brain, allowing toxic substances to pour into brain tissue in large amounts, scientists report May 16 in the journal Nature.
Zimbabwean antiretroviral drug manufacturers are seeking certification from the World Health Organization to receive U.N. and other multilateral agency funding to produce more affordable antiretroviral drugs.
Researchers at Huntsman Cancer Institute at the University of Utah (U of U) presented the first outcomes evaluation of an adult oncology hospital-at-home program today at the 2020 American Society of Clinical Oncology annual meeting.
Health care has much to learn from innovative high-tech companies, but not in the way most people think, according to a Perspective published today in the New England Journal of Medicine and authored by innovation experts from the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. Innovation, they say, can most effectively achieve meaningful outcomes by testing many new ideas quickly, cheaply, and contextually.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristie A Toman, DO 401 N 9th St, Bismarck, ND 58501-4530 Ph: (701) 530-6000 | Kristie A Toman, DO 765 W Interstate Ave, Bismarck, ND 58503-0936 Ph: (701) 323-3700 |
News Archive
A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.
A well-known genetic risk factor for Alzheimer's disease triggers a cascade of signaling that ultimately results in leaky blood vessels in the brain, allowing toxic substances to pour into brain tissue in large amounts, scientists report May 16 in the journal Nature.
Zimbabwean antiretroviral drug manufacturers are seeking certification from the World Health Organization to receive U.N. and other multilateral agency funding to produce more affordable antiretroviral drugs.
Researchers at Huntsman Cancer Institute at the University of Utah (U of U) presented the first outcomes evaluation of an adult oncology hospital-at-home program today at the 2020 American Society of Clinical Oncology annual meeting.
Health care has much to learn from innovative high-tech companies, but not in the way most people think, according to a Perspective published today in the New England Journal of Medicine and authored by innovation experts from the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. Innovation, they say, can most effectively achieve meaningful outcomes by testing many new ideas quickly, cheaply, and contextually.
› Verified 4 days ago
Dr. Parveen Suhara Wahab, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000 | |
Ana Tracey Morgan-harris, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-8645 | |
Terry Lynn Dwelle, MD, MPHTM Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 805 N 5th St, Bismarck, ND 58501 Phone: 701-258-1804 | |
Dr. Calsey Mischel, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5918 | |
Himadri Nath, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000 | |
Dr. Joan M Connell, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 701 E Rosser Ave, Bismarck, ND 58501 Phone: 701-751-9500 Fax: 701-751-9508 | |
Dr. Jonathan Marian Rodrigues, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 715 E Broadway Ave, Bismarck, ND 58501 Phone: 701-323-8922 |